<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000413932"><TermName>smoldering myeloma</TermName><TermPronunciation>(SMOLE-der-ing MY-eh-LOH-muh)</TermPronunciation><TermDefinition><DefinitionText>A very slow-growing type of myeloma in which abnormal plasma cells (a type of white blood cell) make too much of a single type of monoclonal antibody (a protein). This protein builds up in the blood or is passed in the urine. Patients with smoldering myeloma usually have no symptoms, but need to be checked often for signs of progression to fully developed multiple myeloma.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000713473" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;smoldering myeloma&quot;" language="en" id="_3"/><MediaLink ref="CDR0000713474" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;mieloma latente&quot;" language="es" id="_4"/><SpanishTermName>mieloma latente</SpanishTermName><SpanishTermDefinition><DefinitionText>Tipo de mieloma de crecimiento lento en el que hay células plasmáticas (tipo de glóbulo blanco) anormales que producen demasiada cantidad de un tipo de anticuerpo monoclonal (una proteína). Esta proteína se acumula en la sangre o se elimina por la orina. Por lo general, los pacientes de mieloma latente no tienen síntomas, pero se los debe vigilar con frecuencia para determinar si presentan signos de avance del mieloma latente hacia un mieloma múltiple completamente desarrollado.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2005-03-24</DateFirstPublished><DateLastModified>2007-04-26</DateLastModified></GlossaryTerm>
